APA

Andras I., Crisan N., Vesa S., Rahota R., Romanciuc F., Lazar A., Socaciu C., Matei D., de Cobelli O., Bocsan I. & Coman R. (20180814). Serum metabolomics can predict the outcome of first systematic transrectal prostate biopsy in patients with PSA <10 ng/ml. : Future oncology (London, England).

Chicago

Andras Iulia, Crisan Nicolae, Vesa Stefan, Rahota Razvan, Romanciuc Florina, Lazar Andrei, Socaciu Carmen, Matei Deliu-Victor, de Cobelli Ottavio, Bocsan Ioan-Stelian and Coman Radu-Tudor. 20180814. Serum metabolomics can predict the outcome of first systematic transrectal prostate biopsy in patients with PSA <10 ng/ml. : Future oncology (London, England).

Harvard

Andras I., Crisan N., Vesa S., Rahota R., Romanciuc F., Lazar A., Socaciu C., Matei D., de Cobelli O., Bocsan I. and Coman R. (20180814). Serum metabolomics can predict the outcome of first systematic transrectal prostate biopsy in patients with PSA <10 ng/ml. : Future oncology (London, England).

MLA

Andras Iulia, Crisan Nicolae, Vesa Stefan, Rahota Razvan, Romanciuc Florina, Lazar Andrei, Socaciu Carmen, Matei Deliu-Victor, de Cobelli Ottavio, Bocsan Ioan-Stelian and Coman Radu-Tudor. Serum metabolomics can predict the outcome of first systematic transrectal prostate biopsy in patients with PSA <10 ng/ml. : Future oncology (London, England). 20180814.